COVID 19 all comers | COVID-19 mild to moderate | ||
COVID 19 hospitalized | COVID 19 all comers | COVID-19 mild to moderate | |
remdesivir | remdesevir external control SOLIDARITY ... NIH NIAID ACTT-1 Mahajan DisCoVeRy ... | Norwegian NOR study ... Andreas ... | GS-US-540-5774, 5 days GS-US-540-5773 ... GS-US-540-5774, 10 days |